Skip to content
HowShorted

ATOSSA THERAPEUTICS, INC. short interest in 2019

In 2019, ATOSSA THERAPEUTICS, INC.'s disclosed short interest ran from 10.06% of shares outstanding on 15 Jan 2019 to 3.71% on 31 Dec 2019, a change of -6.35 percentage points. The year's high was 10.06% on 15 Jan 2019 and its low 2.42% on 30 Sep 2019, averaging 5.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.75 days on 13 Dec 2019. Full history: ATOSSA THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ATOSSA THERAPEUTICS, INC. in 2019

2019 in figures

Start of year
10.06% (15 Jan 2019)
End of year
3.71% (31 Dec 2019)
Change
-6.35 pp
High
10.06% (15 Jan 2019)
Low
2.42% (30 Sep 2019)
Average
5.15%
Highest days to cover
7.75 (13 Dec 2019)
SEC filings marked
8

Every report in 2019

ATOSSA THERAPEUTICS, INC. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201910.06%1.00
31 Jan 20198.47%5.75
15 Feb 20199.63%1.00
28 Feb 20198.36%6.11
15 Mar 20196.85%1.00
29 Mar 20199.62%1.0010-K filed, results (8-K)
15 Apr 20194.33%1.00
30 Apr 20196.49%1.00
15 May 20193.00%1.2310-Q filed, results (8-K)
31 May 20193.42%1.99
14 Jun 20193.44%1.81
28 Jun 20193.90%1.00
15 Jul 20196.74%1.72
31 Jul 20195.25%5.31
15 Aug 20193.42%2.0310-Q filed, results (8-K)
30 Aug 20192.92%4.27
13 Sep 20193.00%2.10
30 Sep 20192.42%2.03
15 Oct 20193.19%1.85
31 Oct 20193.91%3.11
15 Nov 20194.13%5.8910-Q filed, results (8-K)
29 Nov 20193.62%2.66
13 Dec 20193.65%7.75
31 Dec 20193.71%2.74

See also: ATOSSA THERAPEUTICS, INC.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.